Trial intelligence / Profile preview

EURAP and Development pilot study of in utero valproic acid exposure

NL-OMON31656Phase 4Withdrawn

Sponsor
University Medical Center Utrecht
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of valproic acid, sponsored by University Medical Center Utrecht. Planned start Jul 2008; status: withdrawn.

02

Drugs

valproic acid

Beyond the preview

Go deeper on NL-OMON31656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call